The National Agency for Food and Drug Administration and Control has alerted Nigerians of the recall of Losartan potassium tablet by its manufacturers.
A statement by Prof. Moji Adeyeye, NAFDAC’s Director General, on Thursday revealed that the tablet, manufactured by Hetero Labs Limited, Unit – I (API manufacturer), was recalled after detection of some dangerous impurity.
She said that the tablet was used for the treatment of high blood pressure and congestive heart failure.
She said: “NAFDAC has been notified about the recall of Losartan potassium tablet 25 mg, 50 mg and 100 mg by Camber Pharmaceuticals.
“The recall was due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino Butyric Acid, a possible process impurity or contaminant in an active pharmaceutical ingredient.
“Losartan Potassium, USP, is a prescription medication used in the treatment of high blood pressure and congestive heart failure and is packaged in 30ct, 90ct, 500ct, and 1000ct bottles.
“N-Nitroso N-Methyl 4-amino Butyric Acid is a potential human carcinogen.”
Adeyeye advised patients currently on the medication to meet their doctors for possible change in medication.
She said: “Patients should contact their doctor for further guidance and potential change of treatment before they stop taking the product.
“Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the nearest NAFDAC office.”
Trending
- Queues: NNPC says cause of tightness in fuel supply resolved
- LG polls: Oyo declares Friday half working day
- Ondo 2024: Ajayi emerges PDP governorship candidate
- ‘Dey play,’ Nigerians mock prophet who claims world ends today
- Lagos-Calabar Coastal Highway: Demolition for first 3km begins Saturday
- Court subpoenas Lagos prison controller over disobedience to order
- Ondo poll: You’ll be successful tomorrow, Ganduje tells Jimoh Ibrahim, others
- Court sets aside arrest warrant against Fubara’s Chief of Staff